Skip to main content
CVE-2024-0758VulnerabilityPublished Updated

CVE-2024-0758: MolecularFaces · Cross-site Scripting

Affects MolecularFacesSource CVE Database V5

0

Not known to be exploited · CVSS 6.1 Medium : upgrade to 0.3.0 when convenient.

Data as of 25 Oct 2026, 19:02 UTC

CVSS 3.1 base score
6.1Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.5% chance of exploitation in 30 days – higher than 46% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 0.3.0
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 19 Jan 2024

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-25.

What to do

Upgrade ipb-halle/MolecularFaces to 0.3.0.

Affected software

ProductAffectedFixed in
GitHubipb-halle/MolecularFacespkg:github/ipb-halle/MolecularFacesOther threatsAffected
  • <0.3.0
Fixed in
  • 0.3.0

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

If you cannot patch yet, avoid processing untrusted molfiles or implement input validation and sanitization controls where possible to mitigate exploitation risk.

Description

MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.

References

Community reviews

Loading reviews…